Using UV light to prevent infections in patients with central catheters
Therapeutic UV Disinfection System to Prevent Catheter Related Bloodstream Infections (CRBSIs) in Patients with Peripherally Inserted Central Catheters (PICCs)
This study is testing a new way to use UV light to clean the connectors on long-term catheters, which can help keep patients safe from infections while they receive treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Puracath Medical, INC. NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10883567 on NIH RePORTER |
What this research studies
This research focuses on developing a therapeutic system that uses ultraviolet (UV) light to disinfect needleless connectors on Peripherally Inserted Central Catheters (PICCs). The system aims to significantly reduce the presence of harmful microbes and biofilms that can lead to catheter-related bloodstream infections (CRBSIs). By achieving a 99.99% reduction in these pathogens, the study seeks to enhance patient safety and improve outcomes for those requiring long-term catheterization. The project includes preparing for clinical trials and ensuring the system is ready for commercial manufacturing.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have Peripherally Inserted Central Catheters and are at risk for catheter-related bloodstream infections.
Not a fit: Patients who do not have central catheters or those who are not at risk for infections related to catheter use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could greatly reduce the incidence of catheter-related bloodstream infections, leading to improved health outcomes and reduced healthcare costs for patients.
How similar studies have performed: Previous research has shown success with UV disinfection methods in reducing infection rates, indicating a promising approach for this novel application.
Where this research is happening
Newark, UNITED STATES
- Puracath Medical, INC. — Newark, United States (Active)
Researchers
- Principal investigator: Rasooly, Julia — Puracath Medical, INC.
- Study coordinator: Rasooly, Julia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.